切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - ATP synthase - Na /K /Cl- Symporters (NKCCs) - Na /K ATPases

10 件产品

每页
清除全部
  1. Lithium carbonate
    B7705 Lithium carbonate
    中文名: 碳酸锂
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase抑制剂
      ≥2.74 mg/mL
      ≥3.95 mg/mL
  2. Bedaquiline
    B3492 Bedaquiline
    中文名: 贝达喹啉
    Target: ATP synthase
    Summary: 抗结核药物
      ≥22.05 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Furosemide
    A8435 Furosemide
    中文名: 呋塞米
    Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors
    Summary: GABAA受体拮抗剂
      ≥14.9 mg/mL
      insoluble in H2O
  9. Istaroxime
    A3507 Istaroxime
     1 Citation
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase的抑制剂
      Soluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页